Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Ordinary Shares, nominal value 0.05 GBP per share
-
Shares outstanding
-
84,213,667
-
Total 13F shares
-
50,105,712
-
Share change
-
+3,355,634
-
Total reported value
-
$1,309,183,295
-
Put/Call ratio
-
21%
-
Price per share
-
$26.13
-
Number of holders
-
88
-
Value change
-
+$112,055,574
-
Number of buys
-
55
-
Number of sells
-
33
Institutional Holders of Verona Pharma plc - Ordinary Shares, nominal value 0.05 GBP per share (VRNA) as of Q4 2022
As of 31 Dec 2022,
Verona Pharma plc - Ordinary Shares, nominal value 0.05 GBP per share (VRNA) was held by
88 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
50,105,712 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., NEA Management Company, LLC, PERCEPTIVE ADVISORS LLC, ORBIMED ADVISORS LLC, WELLINGTON MANAGEMENT GROUP LLP, Deep Track Capital, LP, Fairmount Funds Management LLC, Frazier Life Sciences Management, L.P., Octagon Capital Advisors LP, and Abingworth LLP.
This page lists
88
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.